查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1634165

全球醫學模擬市場 - 2025 - 2033

Global Medical Simulation Market - 2025 - 2033
出版日期: | 出版商: DataM Intelligence | 英文 179 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

全球醫學模擬市場在2024年達到24億美元，預計到2033年將達到94億美元，在2025-2033年預測期間複合年成長率為16.4%。

醫學模擬是系統地使用先進的工具、技術和技術來複製現實生活中的醫療場景、程序和環境，以用於醫療保健領域的培訓、教育、評估和研究。它涉及創建現實、互動式和受控的環境，使醫療保健專業人員能夠練習臨床技能、決策、團隊合作和溝通，而不會給真正的患者帶來風險。醫學模擬致力於反映實際的醫療狀況、解剖結構、生理反應和臨床環境。其範圍可以從實體模型（人體模型）到沉浸式數位環境（虛擬實境）。

在技​​術進步、對患者安全的日益重視以及對微創治療的需求不斷成長的推動下，醫療模擬市場經歷了顯著成長。醫學教育機構的擴張導致對為學生提供實踐培訓的模擬工具的需求更高。

例如，根據世界醫學院名錄，世界上 195 個國家大約有 3,965 所醫學院/學校。在這總共3,965所醫學院中，亞洲48個國家有1,865所（47%）醫學院，拉丁美洲33個國家有894所（23%）醫學院，歐洲44個國家有559所（14%）醫學院，非洲54個國家有368所（9%）醫學院，北美（美國和加拿大）有215所（5%）醫學院，大洋洲澳大利亞和紐西蘭等14個國家有38所（1%）醫學院。

市場動態：

驅動程式和限制

醫學模擬技術不斷進步

醫療模擬技術的不斷進步極大地推動了醫療模擬市場的成長，預計將在預測期內推動市場的發展。虛擬實境 (VR) 和擴增實境 (AR) 技術可以創造高度互動的沉浸式環境，醫療專業人員可以在其中透過高階功能在受控環境中練習外科手術、診斷疾病或管理緊急情況。

例如，2024年11月，VRAD有限公司向國際市場推出了兩款廣受認可的韓國開發的基於虛擬實境的模擬器：護理技能教育模擬器NS_Core和創傷患者護理模擬器IP_Trauma。這些產品支援多種語言，包括韓語、英語、越南語、泰語、印尼語、中文、日語、哈薩克語和德語，預計今年底將支援西班牙語和法語。

此外，2023 年6 月，復甦、病患照護和緊急護理訓練領域的模擬訓練提供者挪度醫療(Laerdal Medical) 與虛擬實境(VR) 醫療模擬平台SimX 宣佈建立合作夥伴關係，以幫助提高病患照護質量。

人工智慧驅動的系統可以分析學員的表現並提供個人化回饋，幫助他們提高特定技能。人工智慧驅動的模擬還可以即時適應，根據學習者先前的反應創建新的場景，從而增強學習體驗。人工智慧被用來自動評估醫學模擬，為學員的技能提供更準確、客觀的評估。

例如，2023 年 10 月，Lumeto 宣布對其 InvolveXR 平台進行具有里程碑意義的人工智慧升級。 InvolveXR 是一個完全沉浸式且高度靈活的 XR 模擬實驗室，適合希望在整個醫療保健領域部署沉浸式培訓和評估的機構。該平台配備了基於人工智慧驅動的大型語言模型 (LLM) 的可自訂對話系統，為模擬虛擬患者就診提供了前所未有的適應性。

與醫療模擬器相關的高成本

與醫療模擬器相關的高成本預計將阻礙醫療模擬市場的成長。雖然該技術已被證明在培訓醫療保健專業人員方面非常有效，但其高昂的價格阻礙了廣泛採用，特別是在小型醫療機構、教育機構和資源匱乏的環境中。例如，據 Healthy Simulation 稱，病人模擬器的價格通常從 10,000 美元到 100,000 美元不等，具體取決於類型、品牌、功能和所包含的支援服務。

此外，模擬各種醫療狀況的高保真人體模型不僅在購買方面需要大量投資，而且在維護和校準方面也需要大量投資。例如，一個基本的病人模擬器的價格從 20,000 美元到 40,000 美元不等，而具有完整功能的更先進的系統可能超過 250,000 美元。

由於模擬器成本高昂，機構可能只能購買有限數量的設備，這限制了可以從模擬訓練中受益的學生或醫療保健專業人員的數量。這降低了醫學模擬程序的整體影響並阻礙了廣泛採用。在醫學院，有限數量的模擬器可能一次只能允許一小群學生進行培訓，從而降低了學習過程的有效性並延遲了跨部門的更廣泛採用。

目錄

第1章：市場介紹和範圍

  • 報告的目標
  • 報告範圍和定義
  • 報告範圍

第 2 章：高階主管見解與要點

  • 市場亮點和戰略要點
  • 主要趨勢和未來預測
  • 按產品類型分類的片段
  • 技術片段
  • 按應用程式片段
  • 最終使用者的片段
  • 按地區分類的片段

第 3 章：動力學

  • 影響因素
    • 促進要素
      • 醫學模擬技術不斷進步
    • 限制
      • 與醫療模擬器相關的高成本
    • 機會
    • 影響分析

第 4 章：策略洞察與產業展望

  • 市場領導者和先驅
    • 新興先鋒和傑出參與者
    • 擁有最大銷售品牌的知名領導者
    • 擁有成熟產品的市場領導者
  • 新興新創企業和關鍵創新者
  • CXO 觀點
  • 最新進展和突破
  • 案例研究/正在進行的研究
  • 監管和報銷情況
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 波特五力分析
  • 供應鏈分析
  • SWOT分析
  • 未滿足的需求和差距
  • 市場進入和擴張的推薦策略
  • 情境分析：最佳情況、基本情況和最壞情況預測
  • 定價分析和價格動態

第 5 章：醫療模擬市場，依產品類型

  • 模擬病人
  • 介入/手術模擬器
  • 血管內模擬器
  • 超音波模擬器
  • 診斷模擬器
  • 其他

第 6 章：醫療模擬市場（按技術）

  • 虛擬病人模擬
  • 3D列印
  • 程序演練技術

第 7 章：醫療模擬市場（按應用）

  • 醫療訓練
  • 外科培訓
  • 病人照護和管理
  • 其他

第 8 章：醫療模擬市場（按最終用戶）

  • 醫院
  • 軍事組織
  • 醫科大學
  • 護理學校
  • 專科診所

第 9 章：醫療模擬市場，按區域市場分析和成長機會

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲

第 10 章：競爭格局與市場定位

  • 競爭概況和主要市場參與者
  • 市佔率分析與定位矩陣
  • 策略夥伴關係、併購
  • 產品組合和創新的主要發展
  • 公司基準化分析

第 11 章：公司簡介

  • CAE Inc.
    • 公司概況
    • 產品組合和描述
    • 財務概覽
    • 主要進展
    • SWOT分析
  • 3D Systems, Inc.
  • Simulab Corporation
  • Kyoto Kagaku Co., Ltd.
  • Laerdal Medical
  • 3B Scientific
  • Biomed Simulation, Inc.
  • Cardionics Inc.
  • Gaumard Scientific
  • Simulaids

第 12 章：假設與研究方法

  • 資料收集方法
  • 數據三角測量
  • 預測技術
  • 數據驗證和確認

第 13 章：附錄

簡介目錄
Product Code: MD1362

The global medical simulation market reached US$ 2.4 billion in 2024 and is expected to reach US$ 9.4 billion by 2033, growing at a CAGR of 16.4% during the forecast period 2025-2033.

Medical simulation is the systematic use of advanced tools, techniques and technologies to replicate real-life medical scenarios, procedures and environments for the purpose of training, education, assessment, and research in healthcare. It involves creating realistic, interactive, and controlled settings that allow healthcare professionals to practice clinical skills, decision-making, teamwork, and communication without posing risks to real patients. Medical simulation strives to mirror actual medical conditions, anatomy, physiological responses, and clinical environments. This can range from physical models (mannequins) to immersive digital environments (virtual reality).

The medical simulation market experiencing significant growth driven by technological advancements, an increasing emphasis on patient safety and the rising demand for minimally invasive treatments. The expansion of medical education institutions has led to a higher demand for simulation tools to provide hands-on training to students.

For instance, there are approximately 3,965 medical colleges/schools in 195 countries in the world as per the World Directory of Medical Schools. Out of these total 3,965 medical colleges, Asia 48 countries have 1,865 (47%) medical colleges, Latin America 33 countries have 894 (23%) medical colleges, Europe 44 countries have 559 (14%) medical colleges, Africa 54 countries have 368 (9%) medical colleges, North America (USA and Canada) have 215 (5%) medical schools, Oceania 14 countries including Australia and New Zealand have 38 (1%) medical schools.

Market Dynamics: Drivers & Restraints

Rising technological advancements in medical simulation

The rising technological advancements in medical simulation are significantly driving the growth of the medical simulation market and are expected to drive the market over the forecast period. Virtual Reality (VR) and Augmented Reality (AR) technologies enable the creation of highly interactive, immersive environments where medical professionals can practice surgical procedures, diagnose diseases, or manage emergency situations in a controlled setting with advanced features.

For instance, in November 2024, VRAD Co., Ltd. launched two widely recognized Korean-developed virtual reality-based simulators, NS_Core, a nursing skills education simulator, and IP_Trauma, a trauma patient care simulator, for international markets. These products support a broad range of languages, including Korean, English, Vietnamese, Thai, Indonesian, Chinese, Japanese, Kazakh, and German, with Spanish and French language support anticipated by the end of the year.

Additionally, in June 2023, Laerdal Medical, a provider of simulation-based training in the fields of resuscitation, patient care, and emergency care training, and SimX, a virtual reality (VR) medical simulation platform, announced a partnership to help increase patient safety with a VR simulation training solution that prepares providers to deliver optimal care.

AI-powered systems can analyze the performance of trainees and provide personalized feedback, helping them improve specific skills. AI-driven simulations can also adapt in real-time, creating new scenarios based on the learner's previous responses, enhancing the learning experience. AI is being used to automate the assessment of medical simulations, offering more accurate and objective evaluations of a trainee's skills.

For instance, in October 2023, Lumeto announced a landmark AI upgrade to its InvolveXR platform. InvolveXR is a fully immersive and highly flexible XR Simulation Lab for institutions looking to deploy immersive training and assessment across the healthcare spectrum. The platform is equipped with a Large Language Model (LLM) based AI-driven customizable conversational system enabling an unprecedented level of adaptability for simulating virtual patient encounters.

High cost associated with the medical simulators

The high cost associated with medical simulators is expected to hamper the growth of the medical simulation market. While the technology has proven to be highly effective in training healthcare professionals, its high price point prevents widespread adoption, particularly in smaller healthcare facilities, educational institutions, and low-resource settings. For instance, according to Healthy Simulation, a human patient simulator typically ranges in price from $10,000 to $100,000 depending on the type, brand, features and included support services.

Additionally, high-fidelity mannequins that simulate various medical conditions require significant investment not just in purchasing but also in maintenance and calibration. For instance, a basic patient simulator can range from USD 20,000 to USD 40,000, while more advanced systems with full functionality can exceed USD 250,000.

Due to the high cost of simulators, institutions may only be able to purchase a limited number of units, restricting the number of students or healthcare professionals who can benefit from simulation-based training. This reduces the overall impact of medical simulation programs and hinders widespread adoption. In a medical school, a limited number of simulators may only allow a small group of students to train at a time, reducing the effectiveness of the learning process and delaying broader adoption across departments.

Segment Analysis

The global medical simulation market is segmented based on product type, technology, application, end-user and region.

Product Type:

The patient simulators segment is expected to dominate the medical simulation market share

Patient simulators can be used in a wide variety of medical specialties, including emergency care, surgery, anesthesiology, and obstetrics. Their versatility allows medical institutions to train professionals across many disciplines using the same tool, making them a popular choice. Patient simulators allow trainees to practice rare or complex cases without risk to actual patients, improving skills and decision-making. This focus on patient safety has made them a go-to tool for hospitals and medical schools aiming to reduce medical errors.

For instance, in February 2024, IngMar Medical released Aurora, a medical simulation manikin used to train clinicians in all forms of ventilation. Aurora's new Internal Simulated Lung (ISL) is based on the IngMar's ASL 5000 Breathing Simulator technology. The technology elevates medical training by offering a tetherless, internal system that interacts realistically with all forms of ventilation including bag-valve masks, noninvasive, and invasive ventilation.

Manufacturers are constantly improving the capabilities of patient simulators, incorporating advanced features such as artificial intelligence and real-time feedback. These innovations increase the effectiveness of training programs and further boost the segment's dominance.

For instance, in October 2024, YouMakr.ai, a leader in artificial intelligence solutions for medical education, launched its latest innovation: the AI Patient Simulator. This cutting-edge tool is designed to enhance medical training by automatically generating realistic patient scenarios, allowing medical students to practice and apply their theoretical knowledge in a more efficient and engaging manner.

Geographical Analysis

North America is expected to hold a significant position in the medical simulation market share

North America especially the United States and Canada known for its major market players and also leads in the development and integration of innovative simulation technologies, such as virtual reality (VR), augmented reality (AR), and artificial intelligence (AI). These technologies enable highly realistic simulations that are essential for medical training.

For instance, in July 2023, Hard Hat VR, a leading provider of virtual reality (VR) training simulations, and MindWise Innovations, an award-winning service of the non-profit Riverside Community Care that provides evidence-based mental health and substance use services, announced their strategic partnership to develop an innovative suite of VR training simulations focused on mental health in the workplace.

The demand for medical simulation tools is substantial due to the region's focus on reducing medical errors, enhancing patient safety, and improving healthcare outcomes. Simulation-based education is increasingly being adopted to train healthcare professionals in realistic, risk-free environments.

For instance, in January 2024, Simulab Corporation unveiled its latest technology, SimuSkin. This announcement marks a significant milestone in the company's history, showcasing its dedication to advancing the realism and efficacy of healthcare simulation in medical education. SimuSkin is the result of Simulab's persistent efforts in research and development. SimuSkin has been meticulously designed to emulate human tissue with accuracy in appearance, feel, tactile, and surgical response. This advancement not only sets a new benchmark for realism but also ensures longevity and material integrity, elevating the standard of medical simulation.

Asia-Pacific is growing at the fastest pace in the medical simulation market

The Asia-Pacific region faces a significant need to train a growing number of healthcare professionals, as the region deals with a rapidly increasing population, aging demographics, and evolving healthcare demands. Simulation-based training has emerged as a vital tool for equipping healthcare professionals with the necessary skills and knowledge, as it allows hands-on practice in a risk-free environment.

For instance, in July 2024, MediSim VR publicized Chennai's 'first' immersive and interactive VR-training lab at Sri Ramachandra Institute of Higher Education and Research (SRIHER). The virtual reality technology has benefitted more than 4,000 students, enabling what the healthcare simulation training solutions provider MediSim VR describes as "unparalleled access to immersive, hands-on medical training". It offers students realistic medical scenario simulations within a safe environment to help boost procedural competency, skills, and confidence.

Simulation provides a safe and controlled environment for healthcare providers to practice and refine their skills, thereby minimizing the chances of medical errors in real-life scenarios. With increasing patient awareness and expectations for high-quality care in the Asia-Pacific, especially in China, India and Japan, healthcare institutions are turning to simulation to improve competency among medical professionals.

For instance, in December 2024, Fujifilm India introduced the mikoto Colon Model, a groundbreaking endoscopy simulator, during the Indian Association of Gastrointestinal Endosurgeons (IAGES) Prof. Dr. B Krishna Rau Simulation Training Programme in Chennai. This innovative technology reaffirms Fujifilm's commitment to enhancing medical education and improving healthcare outcomes in India. The mikoto Colon Model is a cutting-edge simulation tool that transforms endoscopy training. Its compact and portable design integrates advanced sensors and artificial intelligence, delivering realistic feedback, performance evaluations, and procedural scoring. By fostering precision and confidence, the mikoto Colon Model equips healthcare professionals to provide superior endoscopic care, ultimately benefiting patients.

Competitive Landscape

The major global players in the medical simulation market include CAE Inc., 3D Systems, Inc., Simulab Corporation, Kyoto Kagaku Co., Ltd., Laerdal Medical, 3B Scientific, Biomed Simulation, Inc., Cardionics Inc., Gaumard Scientific, Simulaids and among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global medical simulation market report delivers a detailed analysis with 70 key tables, more than 68 visually impactful figures, and 179 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Product Type
  • 2.4. Snippet by Technology
  • 2.5. Snippet by Application
  • 2.6. Snippet by End-User
  • 2.7. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Technological Advancements in Medical Simulation
    • 3.1.2. Restraints
      • 3.1.2.1. High Cost Associated with the Medical Simulators
    • 3.1.3. Opportunity
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. Emerging Startups and Key Innovators
  • 4.3. CXO Perspectives
  • 4.4. Latest Developments and Breakthroughs
  • 4.5. Case Studies/Ongoing Research
  • 4.6. Regulatory and Reimbursement Landscape
    • 4.6.1. North America
    • 4.6.2. Europe
    • 4.6.3. Asia Pacific
    • 4.6.4. Latin America
    • 4.6.5. Middle East & Africa
  • 4.7. Porter's Five Force Analysis
  • 4.8. Supply Chain Analysis
  • 4.9. SWOT Analysis
  • 4.10. Unmet Needs and Gaps
  • 4.11. Recommended Strategies for Market Entry and Expansion
  • 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.13. Pricing Analysis and Price Dynamics

5. Medical Simulation Market, By Product Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 5.1.2. Market Attractiveness Index, By Product Type
  • 5.2. Patient Simulators*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Interventional/Surgical Simulators
  • 5.4. Endovascular Simulators
  • 5.5. Ultrasound Simulators
  • 5.6. Diagnostic Simulators
  • 5.7. Others

6. Medical Simulation Market, By Technology

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 6.1.2. Market Attractiveness Index, By Technology
  • 6.2. Virtual Patient Simulation*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. 3D Printing
  • 6.4. Procedure Rehearsal Technology

7. Medical Simulation Market, By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Medical Training*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Surgical Training
  • 7.4. Patient Care and Management
  • 7.5. Others

8. Medical Simulation Market, By End-User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.1.2. Market Attractiveness Index, By End-User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Military Organizations
  • 8.4. Medical Universities
  • 8.5. Nursing Schools
  • 8.6. Specialty Clinics

9. Medical Simulation Market, By Regional Market Analysis and Growth Opportunities

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.7.1. U.S.
      • 9.2.7.2. Canada
      • 9.2.7.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.7.1. Germany
      • 9.3.7.2. U.K.
      • 9.3.7.3. France
      • 9.3.7.4. Spain
      • 9.3.7.5. Italy
      • 9.3.7.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.7.1. Brazil
      • 9.4.7.2. Argentina
      • 9.4.7.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.7.1. China
      • 9.5.7.2. India
      • 9.5.7.3. Japan
      • 9.5.7.4. South Korea
      • 9.5.7.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape and Market Positioning

  • 10.1. Competitive Overview and Key Market Players
  • 10.2. Market Share Analysis and Positioning Matrix
  • 10.3. Strategic Partnerships, Mergers & Acquisitions
  • 10.4. Key Developments in Product Portfolios and Innovations
  • 10.5. Company Benchmarking

11. Company Profiles

  • 11.1. CAE Inc.*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
    • 11.1.5. SWOT Analysis
  • 11.2. 3D Systems, Inc.
  • 11.3. Simulab Corporation
  • 11.4. Kyoto Kagaku Co., Ltd.
  • 11.5. Laerdal Medical
  • 11.6. 3B Scientific
  • 11.7. Biomed Simulation, Inc.
  • 11.8. Cardionics Inc.
  • 11.9. Gaumard Scientific
  • 11.10. Simulaids

LIST NOT EXHAUSTIVE

12. Assumption and Research Methodology

  • 12.1. Data Collection Methods
  • 12.2. Data Triangulation
  • 12.3. Forecasting Techniques
  • 12.4. Data Verification and Validation

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us